The optimal strategy for prostate cancer diagnosis is to avoid overdiagnosis, defined as diagnosis of clinically insignificant disease, and undersampling of the gland, which leads to missing clinically significant disease.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Targeted prostate biopsy is a potential solution for decreasing the rate of both overdiagnosis and undersampling of prostate cancer. We focus here on different techniques for targeting prostate lesions identified on multiparametric MR imaging and review different clinical settings in which MR imaging-targeted prostate biopsies are performed.
Magnetic resonance imaging clinics of North America. 2015 Jul 09 [Epub]
S Saeid Dianat, H Ballentine Carter, Katarzyna J Macura
Department of Radiology, University of Minnesota, 420 Delaware Street, SE Minneapolis, MN 55455, USA. , The James Buchanan Brady Urological Institute, The Johns Hopkins University, 600 North Wolfe Street, Marburg 100, Baltimore, MD 21287, USA. , The Russell H. Morgan Department of Radiology and Radiological Science, The James Buchanan Brady Urological Institute, The Johns Hopkins University, 601 North Caroline Street, JHOC 3140C, Baltimore, MD 21287, USA.